ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 892,20
-0,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Gemphire Therapeutics Inc (GEMP)

  7. Gemphire Therapeutics Inc (GEMP) Actualités

GEMP

Gemphire Therapeutics (GEMP)

Gemphire Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GEMP
DateHeureSourceTitreSymboleSociété
31/12/201912h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GEMPGemphire Therapeutics Inc
30/12/201917h22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GEMPGemphire Therapeutics Inc
30/12/201917h08GlobeNewswire Inc.Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
06/12/201922h25Edgar (US Regulatory)Unknown (sec Staff)NASDAQ:GEMPGemphire Therapeutics Inc
06/12/201914h43GlobeNewswire Inc.Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo PharmaceuticalsNASDAQ:GEMPGemphire Therapeutics Inc
08/11/201915h25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GEMPGemphire Therapeutics Inc
07/11/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GEMPGemphire Therapeutics Inc
06/11/201915h16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GEMPGemphire Therapeutics Inc
04/11/201922h27Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:GEMPGemphire Therapeutics Inc
03/09/201912h03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:GEMPGemphire Therapeutics Inc
13/08/201923h27Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
05/08/201914h22Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GEMPGemphire Therapeutics Inc
26/07/201922h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GEMPGemphire Therapeutics Inc
24/07/201922h01GlobeNewswire Inc.Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease CompanyNASDAQ:GEMPGemphire Therapeutics Inc
16/07/201922h03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GEMPGemphire Therapeutics Inc
26/06/201914h00GlobeNewswire Inc.Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Tri...NASDAQ:GEMPGemphire Therapeutics Inc
18/03/201911h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GEMPGemphire Therapeutics Inc
15/03/201913h00GlobeNewswire Inc.Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial ResultsNASDAQ:GEMPGemphire Therapeutics Inc
14/02/201922h09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GEMPGemphire Therapeutics Inc
03/12/201814h00GlobeNewswire Inc.Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
08/11/201822h01GlobeNewswire Inc.Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
24/09/201823h06GlobeNewswire Inc.Gemphire Therapeutics Announces Workforce ReductionNASDAQ:GEMPGemphire Therapeutics Inc
28/08/201816h05Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:GEMPGemphire Therapeutics Inc
22/08/201822h51Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:GEMPGemphire Therapeutics Inc
20/08/201822h12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GEMPGemphire Therapeutics Inc
13/08/201822h01GlobeNewswire Inc.Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:GEMPGemphire Therapeutics Inc
10/08/201817h33Dow Jones NewsGemphire Therapeutics Shares Fall Over 50% in Heavy Trading -- Market MoverNASDAQ:GEMPGemphire Therapeutics Inc
10/08/201812h00GlobeNewswire Inc.Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLDNASDAQ:GEMPGemphire Therapeutics Inc
06/08/201822h01GlobeNewswire Inc.Gemphire Announces Amended and Restated Gemcabene License Agreement with Pfizer Inc.NASDAQ:GEMPGemphire Therapeutics Inc
06/08/201822h01GlobeNewswire Inc.Gemphire Provides Update On Development of GemcabeneNASDAQ:GEMPGemphire Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GEMP

Dernières Valeurs Consultées

BOV
CSRN6F
COSERN PNB
BIT
HI
Health Italia
BIT
P15BS1
BNP Paribas Issuance
EU
GTT
Gaztransport Et Technigaz
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés